Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mikio Ikeda is active.

Publication


Featured researches published by Mikio Ikeda.


AIDS Research and Human Retroviruses | 2000

Genetic subtypes of HIV type 1 in Republic of Congo.

Blaise Bikandou; Jun Takehisa; Innocent Mboudjeka; Eiji Ido; Takeo Kuwata; Yasuyuki Miyazaki; Hiroyuki Moriyama; Yosuke Harada; Yuko Taniguchi; Hiroshi Ichimura; Mikio Ikeda; Patrice Juste Ndolo; Marie Yvonne Nzoukoudi; Reine M'Vouenze; Michel M'Pandi; Henri Jopseph Parra; Pierre M'Pelé; Masanori Hayami

To assess the molecular epidemiology of HIV-1 in Republic of Congo (Congo), we investigated 29 HIV-1s obtained from 82 Congolese AIDS and ARC patients in 1996 and 1997. Part of the env region including the V3 loop was phylogenetically analyzed. The genotypes observed were varied: of 29 specimens, 12 (41 %) were subtype A, 1 (3%) was subtype D, 6 (21%) were subtype G, 6 (21%) were subtype H, 2 (7%) were subtype J, and 2 (7%) could not be classified as any known subtypes (U, unclassified). The heterogeneous profile of HIV-1 infection was different from the profiles of neighboring Central African countries. These data show that subtypes G and H as well as subtype A were circulating with high prevalence. The fact that new genetic subtypes (J and U) are circulating indicates a need for a greater surveillance for these subtypes both in Congo as well as in other parts of the world.


Journal of Virology | 2002

High Prevalence of Simian T-Lymphotropic Virus Type L in Wild Ethiopian Baboons

Taichiro Takemura; Masahiro Yamashita; Makoto K. Shimada; Sadayuki Ohkura; Takayoshi Shotake; Mikio Ikeda; Tomoyuki Miura; Masanori Hayami

ABSTRACT Simian T-cell leukemia viruses (STLVs) are the simian counterparts of human T-cell leukemia viruses (HTLVs). A novel, divergent type of STLV (STLV-L) from captive baboons was reported in 1994, but its natural prevalence remained unclear. We investigated the prevalence of STLV-L in 519 blood samples from wild-living nonhuman primates in Ethiopia. Seropositive monkeys having cross-reactive antibodies against HTLV were found among 22 out of 40 hamadryas baboons, 8 of 96 anubis baboons, 24 of 50 baboons that are hybrids between hamadryas and anubis baboons, and 41 of 177 grivet monkeys, but not in 156 gelada baboons. A Western blotting assay showed that sera obtained from seropositive hamadryas and hybrid baboons exhibited STLV-L-like reactivity. A PCR assay successfully amplified STLV sequences, which were subsequently sequenced and confirmed as being closely related to STLV-L. Surprisingly, further PCR showed that nearly half of the hamadryas (20 out of 40) and hybrid (19 out of 50) baboons had STLV-L DNA sequences. In contrast, most of the seropositive anubis baboons and grivet monkeys carried typical STLV-1 but not STLV-L. These observations demonstrate that STLV-L naturally prevails among hamadryas and hybrid baboons at significantly high rates. STLV-1 and -2, the close relative of STLV-L, are believed to have jumped across simian-human barriers, which resulted in widespread infection of HTLV-1 and -2. Further studies are required to know if STLV-L is spreading into human populations.


Japanese Journal of Cancer Research | 1991

Improvement of Gelatin Particle Agglutination Test for Detection of Anti-HTLV-I Antibody

Ryuichi Fujino; Katsuhito Kawato; Mikio Ikeda; Hideo Miyakoshi; Mikio Mizukoshi; Joko Imai

Partial modifications of antigen components were made to improve the gelatin particle agglutination (PA) test for the detection of antibodies against human T cell leukemia virus type‐I. Envelope glycoproteins prepared by lentil lectin affinity chromatography were further added to the purified viral antigens to be coated on the gelatin particles. Comparative studies with a conventional PA test kit (Serodia ATLA) and indirect immunofluorescence assay showed that the specificity and sensitivity of the new PA test were increased and that abnormal agglutination such as the prozone phenomenon was abolished by this improvement.


AIDS Research and Human Retroviruses | 2001

Natural Infection of Wild-Born Mandrills (Mandrillus sphinx) with Two Different Types of Simian Immunodeficiency Virus

Jun Takehisa; Yosuke Harada; Nicaise Ndembi; Innocent Mboudjeka; Yuko Taniguchi; Charlotte Ngansop; Seraphin Kuate; Leopold Zekeng; Kentaro Ibuki; Toshihide Shimada; Blaise Bikandou; Yumi Yamaguchi-Kabata; Tomoyuki Miura; Mikio Ikeda; Hiroshi Ichimura; Lazare Kaptue; Masanori Hayami

We found a novel primate lentivirus in mandrill (Mandrillus sphinx). To clarify the evolutionary relationships and transmission patterns of human/simian immunodeficiency virus (HIV/SIV), we screened blood samples from 30 wild-born healthy Cameroonian mandrills. Five (16.7%) of them were seropositive for SIV. Three SIV strains were isolated from the five seropositive mandrills by cocultivation of their peripheral blood mononuclear cells (PBMCs) with PBMCs of rhesus macaques, a human T cell line (M8166), and/or a cynomolgus macaque T cell line (HSC-F). One of the newly isolated SIV strains was intravenously inoculated into two rhesus macaques and resulted in chronic infection. In the SIV-infected macaques at 45 weeks after inoculation, we observed a mild decline in the number of peripheral CD4(+) lymphocytes, lymphadenopathy, and blastic follicular dendritic cells with mild follicular hyperplasia in the peripheral lymph nodes. A phylogenetic analysis based on the pol sequence showed that the newly found SIVs from Cameroonian mandrills did not cluster with SIVmndGB1, which is the former representative strain of SIVmnd. The SIVmnds from Cameroon formed a new, independent lineage that branched before the root of the HIV-1/SIVcpz lineage with 996 of 1000 bootstrap replications. They clustered host specifically, and exhibited about 16.9% diversity at the level of nucleotide sequence among Cameroonian SIVmnd strains. These results indicate that the SIVmnds isolated in Cameroon are a novel type of SIVmnd and have infected Cameroonian mandrills for a long time. We therefore designated the Cameroonian SIVmnd as SIVmnd type 2 and redesignated SIVmndGB1 as SIVmnd type 1. To date, M. sphinx is the only primate species other than humans that is naturally infected with two different types of SIV.


Japanese Journal of Cancer Research | 1997

Prevalence and Phylogenetic Analysis of HTLV–I Isolates in Cameroon, Including Those of the Baka Pygmy

Innocent Mboudjeka; Leopold Zekeng; Masahiro Yamashita; Jun Takehisa; Eiji Ido; Tomoyuki Miura; Sadayuki Ohkura; Mikio Ikeda; Lazare Kaptue; Masanori Hayami

Our previous analysis of an HTLV–I isolate (CMR229) from a Cameroonian Pygmy demonstrated that the isolate is distinct from typical HTLV–ls of the “Central African group,” which has a close similarity to HTLV–I–related simian viruses (STLV–I) in Africa. In this study, we analyzed six new HTLV–ls from Cameroon consisting of three isolates from the Pygmy and three from the Bantu to examine further the genetic features of HTLV–I in Cameroon, especially in the Pygmy. A phylogenetic tree based on the long terminal repeats (LTR) region showed that all the new HTLV–ls belong to the Central African group. On the other hand, an env–based analysis of CMR229 confirmed the previous finding derived from LTR–based analysis that CMR229 has a similarity to African STLV–Is, but is distinct from the typical Central African group of HTLV–I. This suggests that multiple interspecies transmissions from non–human primates to humans have occurred in Central Africa, resulting in the presence of two distinct HTLV–I strains in this area. In addition, it seems likely that the Pygmy harbors the heterogeneous HTLV–I strains from which the main HTLV–I population spread into the Bantu.


Kobunshi Ronbunshu | 1993

Preparation of Gelatin Particles for Use in Passive Agglutination Immunoassay.

Masato Nakamura; Ryuichi Fujino; Mikio Ikeda


Archive | 1987

Reagent for detecting antibody to viral antigen

Mikio Ikeda; Mikio Mizukoshi


Archive | 1987

Reagens foer bestaemning av antikropp mot virusantigen.

Mikio Ikeda; Mikio Mizukoshi


Archive | 1987

Reagent Foer bestaemning of antikropp against virusantigen.

Mikio Ikeda; Mikio Mizukoshi


Archive | 1987

Reagent Foer bestaemning antikropp av mot virusantigen.

Mikio Ikeda; Mikio Mizukoshi

Collaboration


Dive into the Mikio Ikeda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge